Determining how to utilize new treatments for complement 3 glomerulopathy

NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Paolo Cravedi, MD, PhD, discusses the treatment landscape in complement 3 glomerulopathy. Cravedi, professor in the division of nephrology at the Icahn School of Medicine at Mount Sinai, highlights the effectiveness of new treatments for complement 3 glomerulopathy in both transplant and native cases.